Minerva Capital
Minerva Capital, established in 2004 and headquartered in Madrid, Spain, is an independent investment group focused on private equity. The firm specializes in sourcing investments in Spanish-based businesses across various sectors, including manufacturing, life sciences, beauty, e-commerce, health technology, and robotics. With a management-owned structure, Minerva Capital emphasizes a hands-on approach, leveraging its team's extensive experience to provide tailored investment solutions and strategic support to its portfolio companies. The firm is committed to maintaining objectivity in its investment and advisory processes, ensuring that clients engage directly with decision-makers. In addition to traditional equity investments, Minerva Capital offers assistance in refinancing, restructuring, growth capital, disposals, and bolt-on acquisitions, demonstrating its versatility in addressing diverse client needs.
Top Stages
2 past transactions
Tract
Seed Round in 2020
Tract is an online educational platform designed specifically for children aged 8 and older, focusing on student-directed learning. The platform provides unlimited access to a diverse library of engaging courses, covering topics such as video game development and sports writing, along with vibrant weekly live events led by accomplished creators and mentors. This approach encourages children to explore their passions through real-world lessons, fostering essential skills and a mindset suited for 21st-century challenges. Founded on the TRICK philosophy—Trust, Respect, Independence, Collaboration, and Kindness—Tract aims to empower young learners to become innovators and global citizens. The company’s mission is rooted in the belief that children are capable of more than commonly perceived and that education should prioritize creativity and self-directed learning over standardization. By addressing issues such as the achievement gap and career readiness, Tract seeks to create a more equitable educational landscape that nurtures the next generation of leaders.
Genoclinics Biotech
Acquisition in 2012
Genoclinics offers a global solution to all human genetics for health professionals, the global solution includes all the stages: Prevention (Study of the probability of suffering a disease), Genetic Diagnosis (study of the genetics of a disease that is suffered) and pharmacogenetics, oriented to treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.